PATH | VRL
Menu

Find resources

Total results with these characteristics: 1178

Topic: Disease/vaccine specific information

Page 5 of 59
The Case for Investment in Enterotoxigenic Escherichia coli Vaccines

This market assessment aims to increase the awareness of biotechnology and pharmaceutical companies worldwide about the opportunities and potential markets that exist for low-cost and effective vaccines against enterotoxigenic Escherichia coli …

Author: PATH; BIO Ventures for Global Health

Publication date: 2011

A Case Study Using the United Republic of Tanzania: Costing Nationwide HPV Vaccine Delivery Using the WHO Cervical Cancer Prevention and Control Costing Tool

This article, published in BMC Medicine, reports on a study to determine the cost of establishing a human papillomavirus (HPV) vaccine program that delivers three doses of vaccine to girls at schools via phased national introduction in Tanzania. It …

Author: Hutubessy R, Levin A, Wang S, et al.

Publication date: 2012

Center for Vaccine Innovation and Access

This website provides information about the work of PATH’s Center for Vaccine Innovation and Access, which brings together expertise across every stage of vaccine research, development, and introduction to make lifesaving vaccines globally …

Author: PATH

Cervical Cancer Action: 2007 to 2014 . . . and Beyond

This briefing paper highlights Cervical Cancer Action's accomplishments and global milestones, engagements and country support, and plans for future investment. It includes a detailed timeline which spans from 2007 to 2013 and a map of the rapid …

Author: Cervical Cancer Action

Publication date: 2014

Cervical Cancer, Cervical Dysplasia, Genital Warts: The Pathogenesis and Clinical Outcomes of HPV Anogenital Infections

This technical six-minute animation explains what HPV is, shows how it infects human tissue, and how disease progresses. It also provides disease burden information specific to HPV and cervical cancer.

Author: Sanofi Pasteur MSD

Publication date: 2006

Cervical Cancer Prevention Action Planner

This interactive tool is designed for public health officials seeking guidance and resources related to developing evidence-based cervical cancer prevention programs in their countries. It includes video mini-lectures and other films, impact models, …

Author: PATH

Publication date: 2012

Cervical Cancer Prevention and HPV Vaccines

This fact sheet outlines the types of support the GAVI Alliance offers for the introduction of human papillomavirus (HPV) vaccines in eligible countries. It also links to the specific requirements for country applications.

Author: GAVI Alliance

Publication date: 2014

Cervical Cancer Prevention and the Millennium Development Goals

This article, published in the Bulletin of the World Health Organization, explores how scaled-up cervical cancer prevention activities, including introduction of the new HPV vaccines and increased access to precancer screening and treatment, can …

Author: Wittet S, Tsu V

Publication date: 2008

Cervical Cancer Prevention at PATH: Two Decades of Progress Toward a World Free of HPV-Related Cancers

This report describes PATH's key cervical cancer prevention initiatives, which include providing technical assistance with human papillomavirus (HPV) vaccine program strategy and planning to low- and middle-income countries.

Author: PATH

Publication date: 2013

Cervical Cancer Screening and Treatment in Low-Resource Settings: Practical Experience From PATH

From 2006 to 2011, PATH conducted human papillomavirus (HPV) vaccination demonstration projects in India, Peru, Uganda, and Vietnam to provide evidence for decision-making about public-sector introduction of HPV vaccines. This report examines the …

Author: PATH

Publication date: 2013

Cervical Cancer: The Real Lady Killer

This film in the BBC’s "Kill or Cure?" series uncovers the challenges of preventing and treating cervical cancer in Africa and highlights exciting new opportunities for dramatically reducing the toll of disease. The BBC crew follows Sarah …

Author: PATH, Rockhopper Productions

Publication date: 2009

Challenges and Opportunities for Respiratory Syncytial Virus Vaccines

This book chapter, published in Current Topics in Microbiology and Immunology, summarizes what is known about the virology, clinical manifestation, immunity, pathogenesis, and epidemiology of respiratory syncytial virus (RSV) as it relates to …

Author: Graham BS, Anderson LJ, eds.

Publication date: 2013

Challenges Faced by the Global Polio Eradication Initiative

After the World Health Assembly resolved in 1988 to eradicate wild poliovirus (WPV) transmission globally by 2000, dramatic progress in reducing polio cases and increasing the number of countries that interrupted indigenous WPV transmission was …

Author: Wassilak S, Orenstein W

Publication date: 2010

Changes in Hospitalisations for Acute Gastroenteritis in Australia After the National Rotavirus Vaccination Program

This retrospective analysis, published in the Medical Journal of Australia, found a sustained and substantial decline in rotavirus hospitalizations as well as hospitalizations for diarrhea of any cause following national vaccine …

Author: Dey A, Wang H, Menzies R, Macartney K

Publication date: 2012

Changes in Neisseria meningitidis Disease Epidemiology in the United States, 1998-2007: Implications for Prevention of Meningococcal Disease

This article, published in Clinical Infectious Diseases, describes the epidemiologic landscape of meningococcal disease in the United States from 1998 to 2007, including an analysis of the disease before and during the implementation of adolescent …

Author: Cohn AC, MacNeil JR, Harrison LH, et al.

Publication date: 2010

Changes in the Prevalence of Human Papillomavirus Following a National Bivalent Human Papillomavirus Vaccination Programme in Scotland: A 7-Year Cross-Sectional Study

This article, published in The Lancet Infectious Diseases, reports on a cross-sectional study that examined effectiveness of the bivalent human papillomavirus (HPV) vaccine against HPV types 16, 18, 31, 33, 45, and other high-risk types, after the …

Author: Kavanagh K, Pollock KG, Cuschieri K, et al.

Publication date: 2017

The Changing Epidemiology of Meningococcal Disease in North America 1945–2010

The epidemiology of Invasive Meningococcal Disease (IMD) is distinct in the United States and Canada compared with other countries. This review, published in Human Vaccines & Immunotherapeutics, describes the incidence, mortality, and …

Author: Baccarini C, Ternouth A, Wieffer H, Vyse A

Publication date: 2013

The Changing Landscape of Respiratory Syncytial Virus

Recognition of the high disease burden of respiratory syncytial virus (RSV) has led to increased efforts to prevent and treat RSV. This article, published in Vaccine, attempts to address questions that may emerge using current knowledge from the …

Author: Polack FP

Publication date: 2015

Chapter 25: Education, Training, and Communication for HPV Vaccines

The authors of this article, which is a chapter in a monograph published in Vaccine, purport that as HPV vaccines come to market, they will face education and training challenges similar to those of other new vaccines, along with HPV-specific …

Author: Sherris J, Friedman A, Wittet S, Davies P, Steben M, Saraiya M

Publication date: 2006

Characterization and Standardization of Sabin Based Inactivated Polio Vaccine: Proposal for a New Antigen Unit for Inactivated Polio Vaccines

To prepare for the post-eradication period of polio and meet expected demand for inactivated polio vaccine (IPV), the production capacity of wild-type IPV needs to increase. However, the strains used for this process require stringent containment …

Author: Westdijk J, Brugmans D, Martin J, et al.

Publication date: 2011

Page 5 of 59